Rigel Pharmaceuticals Operating Expenses 2011-2026 | RIGL

Annual Operating Expenses Rigel Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	127 M	117 M	84.1 M	84.4 M	80.6 M	99.5 M	94.9 M	102 M	91.1 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
127 M	80.6 M	97.9 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	948 M	$ 20.32	-1.86 %	$ 2.56 B	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Aptorum Group Limited APM	20.7 M	$ 0.82	-2.7 %	$ 4.47 M	China
Axsome Therapeutics AXSM	99.1 M	$ 165.39	-0.6 %	$ 8.23 B	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
AbCellera Biologics ABCL	292 M	$ 3.65	-4.58 %	$ 1.09 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
Burford Capital Limited BUR	106 M	$ 8.35	-4.41 %	$ 1.4 B	Britain
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Corvus Pharmaceuticals CRVS	23.4 M	$ 17.24	-3.63 %	$ 828 M	USA
ARCA biopharma ABIO	88.1 M	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	24.6 M	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	88.2 M	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	49.3 M	$ 25.62	-4.62 %	$ 686 M	USA
Acasti Pharma ACST	24.4 M	-	4.01 %	$ 150 M	Canada
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	10.1 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Codexis CDXS	31.5 M	$ 0.99	-2.59 %	$ 72.7 M	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	29.7 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	46 M	$ 3.18	-4.94 %	$ 1.14 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	543 M	$ 28.47	-2.5 %	$ 1.65 B	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Завод ДИОД DIOD	249 M	-	-	-	Russia
Фармсинтез LIFE	201 M	-	-	-	Russia
Albireo Pharma ALBO	163 M	-	-0.23 %	$ 916 M	USA
Cellectis S.A. CLLS	109 M	$ 3.64	-4.21 %	$ 116 M	France
Alector ALEC	177 M	$ 2.13	-3.39 %	$ 219 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	65.1 M	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	103 M	$ 4.15	-0.24 %	$ 295 M	USA
Teligent, Inc. TLGT	548 K	-	-13.85 %	$ 16.1 M	USA
AlloVir ALVR	65.4 M	-	4.14 %	$ 49.1 M	USA
Viela Bio, Inc. VIE	163 M	-	-	$ 2.91 B	USA
Ampio Pharmaceuticals AMPE	9.57 M	-	-11.43 %	$ 502 K	USA
Catalyst Pharmaceuticals CPRX	206 M	$ 24.06	0.75 %	$ 2.94 B	USA
Amarin Corporation plc AMRN	171 M	$ 13.95	0.14 %	$ 5.79 B	Irlanda
AbbVie ABBV	12.8 B	$ 231.93	-0.98 %	$ 410 B	USA
Blueprint Medicines Corporation BPMC	428 M	-	-	$ 8.14 B	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA